Related Experiment Videos
Abstract:
In 27 patients nitrazepam (Mogadon) taken in acute overdosage produced no untoward effects except drowsiness, even when 80 tablets were consumed. A double-blind trial in patients in general medical wards established that nitrazepam was as effective as butobarbitone as a hypnotic. It is concluded that nitrazepam is a safe and effective hypnotic.
Insights
Nitrazepam (Mogadon) showed no adverse effects in acute overdose, even with 80 tablets. Clinical trials confirm nitrazepam is a safe and effective hypnotic, comparable to butobarbitone.
Area of Science:
- Pharmacology
- Clinical Medicine
Background:
- Nitrazepam is a widely prescribed hypnotic medication.
- Assessing the safety and efficacy of hypnotics is crucial for patient care.
Purpose of the Study:
- To evaluate the safety profile of nitrazepam in acute overdosage.
- To compare the hypnotic efficacy of nitrazepam with butobarbitone in a clinical setting.
Main Methods:
- A study involving 27 patients who ingested varying amounts of nitrazepam.
- A double-blind, randomized controlled trial comparing nitrazepam with butobarbitone in general medical ward patients.
Main Results:
- No significant adverse effects were observed in patients taking nitrazepam, even in large doses (up to 80 tablets).
- Nitrazepam demonstrated comparable hypnotic effectiveness to butobarbitone in a double-blind trial.
Conclusions:
- Nitrazepam is a safe medication, even in cases of acute overdosage.
- Nitrazepam is an effective hypnotic agent, offering a viable alternative to other sedatives.